US-guided SAPB for Rib Fractures in the ED

• Status: Unknown status
• Trial end date: 2019-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this randomized controlled study is to determine whether the serratus anterior plane block reduces pain more than the usual treatment for rib fractures in the same amount of time.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Andrew A Herring
• Collaborators: Oregon Health and Science University; University of California, Los Angeles
• Treatments: Acetaminophen; Bupivacaine; Fentanyl; Gabapentin; Hydrocodone; Hydromorphone; Ibuprofen; Ketamine; Ketorolac; Morphine

Criteria

Inclusion Criteria:

• Males and females 18 years and older, capable of providing informed consent indicating awareness of the investigational nature of the study, in keeping with institutional policy.

• Written informed consent must be obtained from each patient prior to entering the study.

• Patients with moderate to severe pain (NRS 4 to 10) as a result of one or more rib fractures occurring at levels T2-T8, measured on a self-reported NRS.

Exclusion Criteria:

• Patient refusal

• Patients with significant pain from other injuries (as determined at the discretion of the treating physician)

• Patients deemed critically ill by provider

• Patients with decompensated psychiatric disorders

• Pregnant patients (positive urine or serum B-HCG)

• History of heart block or bradycardia

• History of uncontrolled seizures

• Patients allergic to lidocaine, bupivacaine, ropivacaine, or morphine

• Patients with bilateral rib fractures